Congratulations to second year PhD student Anu Trivedi for her accepted abstract by RSNA titled “Imaging biomarkers for predicting overall and progression-free survival of newly diagnosed GBM in a clinical trial”! Through a secondary analysis of our Dose Escalation trial, she found trends that suggest that the volume of metabolically abnormal tissue in the brain is highly correlative with patient survival and time to progression, unlike that for residual enhancing tumor volumes. For her work, she will be presenting at the Radiological Society of North America conference in Chicago this December.